MedPath

Efficacy and Safety of Cornelian Cherry compounds on reducing body weight and body fat in overweight women subjects; Controlled Clinical Trial

Not Applicable
Active, not recruiting
Conditions
Factors influencing health status and contact with health servisces
Registration Number
KCT0003875
Lead Sponsor
INE B
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

1) person with BMI of 25kg/m2 or higher and less than 30g/m2

Exclusion Criteria

1) Subject with severe cerebrovascular disease (infarct, hemorrage), cardiac disease (angina, myocardiac infarct, heart failure, arrhythmias that require treatment) within recent 6 months. (If that patient's clinical status is stable, they can participate in the clinical trial according to investgator)
2) people who has taken medications affect weight within the past month.
3) Patiens uncontrolled hypertension
4) Diabetic patients with fasting blood glucose greater than or equal to 126 mg / dl or those receiving oral hypoglycemic agents or insulin

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body fat percentage and fat mass by Dual-energy X-ray Absorptiometry
Secondary Outcome Measures
NameTimeMethod
weight;Waist circumference, Hip circumference;Visceral Fat Area, Subcutaneous Fat Area, Taoal Fat Area,Visceral fat / Subcutanesou Fat Ratio by CT;Total Cholesterol, HDL-Cholesterol, LDL-Cholesterol, Triglyceride;Adiponectine
© Copyright 2025. All Rights Reserved by MedPath